NCT01691781View on ClinicalTrials.gov

The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions
Hyperparathyroidism
Interventions
DRUG

Lisinopril

Each subject will receive one week of lisinopril and return for repeat for blood measurements.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT01691781 - The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study | Biotech Hunter | Biotech Hunter